MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

509589

Report Date :

24.05.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

COPMED PHARMACEUTICALS PRIVATE LIMITED

 

 

Registered Office :

7, Vasant Marg, IInd Floor, Vasant Vihar, New Delhi-110057

Mob. No.:

91-9816634189 [Mr. Rajeev Gupta]

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

13.09.1988

 

 

Com. Reg. No.:

55-033151

 

 

Capital Investment / Paid-up Capital :

INR 9.600 Million

 

 

CIN No.:

[Company Identification No.]

U74899DL1988PTC033151

 

 

IEC No.:

[Import-Export Code No.]

Not Divulged

 

 

GSTN :

[Goods & Service Tax Registration No.]

02AAACC6076B2Z9

 

 

TIN No.:

02040201263

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAACC6076B

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

·         Manufacturer and Supplier of Syrup, Tables and HP Black Ink Cartridge, etc. [Confirmed by Management]

 

·         Manufacturing Drugs and Pharmaceuticals. [Registered Activity]

 

 

No. of Employees :

150 (Approximately)

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Maximum Credit Limit :

USD 2226900

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in the year 1988. The company is a manufacturer and supplier of syrup, tablets, capsules, etc.

 

As per the financial records of 2017, the company has achieved a favourable growth of 34.80% in its revenue as compared to the previous year and has reported a fair net profit margin of 7.36%.

 

The company possesses healthy financial position marked by sound net worth base along with satisfactory liquidity profile.

 

Rating takes into consideration the company’s decent Earnings Per Share (EPS) of INR 1896.56 as against its Face Value (FV) of INR 100.

 

Business is active. Payment seems to be regular.

 

In view of aforesaid, the company can be considered good for normal business dealings at usual trade terms and condition. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2018.

 

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 24.05.2018.

 

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

INFORMATION PARTED BY

 

Name :

Mr. Rajeev Gupta

Designation :

Accounts Manager

Contact No.:

91-9816634189

Date :

17.05.2018

 

 

LOCATIONS

 

Registered Office :

7, Vasant Marg, IInd Floor, Vasant Vihar, New Delhi-110057, India

Tel. No.:

Not Available

Mobile No.:

91-9816634189 [Mr. Rajeev Gupta]

Fax No.:

Not Available

E-Mail :

sales@copmedpharma.com

rajeev.gupta@copmedpharma.com

caguptashiv@gmail.com

Website :

http://copmedpharma.com

Location :

Leased

Locality :

Industrial

 

 

Factory :

Plot No. 50, Industrial Area, Gondpur, Paonta Sahib, Sirmour-173025, Himachal Pradesh, India

Tel. No.:

91-1704-265075/ 265015

Fax No.:

91-1704-265015

 

 

DIRECTORS

 

AS ON: 31.03.2017

 

Name :

Mr. Veer Pal Singh

Designation :

Director

Address :

202/14, Ward No. 4, Near Sbi Taruwala, Durga Colony, Taruwal A (114), Sirmour-173025, Himachal Pradesh, India

Date of Birth/Age :

20.08.1956

Qualification :

Graduate

Date of Appointment :

31.07.2009

PAN No.:

AETPS4501B

DIN No.:

01193306

Other Directorship :

CIN/FCRN

Company Name

Begin Date

U24231UP1997PTC022390

RELAX PHARMACEUTICALS PRIVATE LIMITED

31/07/1997

U28113DL2012PTC237207

MEDIPACK INNOVATIONS PRIVATE LIMITED

30/09/2013

U41000HP2010PLC031422

SIRMOUR GREEN ENVIRON LIMITED

01/09/2011

 

 

Name :

Mr. Nikunj Tyagi

Designation :

Director

Address :

H No 172/3, Ward No 5 Yamuna Vihar Shamsherpur, Paonta Sahib, Sirmour- 173025, Himachal Pradesh, India

Date of Birth/Age :

28.07.1981

Qualification :

Graduate

Date of Appointment :

02.01.2017

DIN No.:

02451567

Other Directorship :

CIN/FCRN

Company Name

Begin Date

U15311HP1989PTC009770

SIRMOUR REMEDIES PRIVATE LIMITED

11/02/2017

U24231UP1997PTC022390

RELAX PHARMACEUTICALS PRIVATE LIMITED

09/09/2013

U51397UP2001PTC025873

MEDIFORCE HEALTHCARE PRIVATE LIMITED

10/02/2017

U52300HR2012PTC047660

CODELIGHT ECOMMERCE SOLUTIONS PRIVATE LIMITED

14/11/2012

U74140HR2015PTC056381

TIGER ROAR HEALTHCARE PRIVATE LIMITED

11/08/2015

 

 

Name :

Mr. Arjun Singh

Designation :

Director

Address :

H.No. 202/14, W.No. 4 Durga Colony, The Paonta Sahib, Sirmour-173025, Himachal Pradesh, India

Date of Appointment :

09.01.2017

PAN No.:

AGEPJ3227A

DIN No.:

07710369

Other Directorship :

CIN/FCRN

Company Name

Begin Date

U15311HP1989PTC009770

SIRMOUR REMEDIES PRIVATE LIMITED

11/02/2017

U24231UP1997PTC022390

RELAX PHARMACEUTICALS PRIVATE LIMITED

09/02/2017

U51397UP2001PTC025873

MEDIFORCE HEALTHCARE PRIVATE LIMITED

10/02/2017

 

 

KEY EXECUTIVES

 

Name :

Mr. Rajeev Gupta

Designation :

Accounts Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON: 31.03.2017

 

Names of Shareholders

No. of Shares

 

Percentage of Holding

Veer Pal Singh

8000

8.33

Saroj Singh

7500

7.81

Sonia Pundir

519

0.54

Seema Singh

1741

1.81

B.D. Tyagi

17760

18.50

Arjun Juneja

23587

24.57

Puja Juneja

19958

20.79

Sheetal Arora

16935

17.64

 

 

 

Total

 

96000

100.00

 

 

AS ON: 22.09.2017

 

Equity Share Breakup

Percentage of Holding

Category

 

Promoters – Individual/ Hindu Undivided Family – Indian

100.00

 

 

Total

 

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

·         Manufacturer and Supplier of Syrup, Tables and HP Black Ink Cartridge, etc. [Confirmed by Management]

 

·         Manufacturing Drugs and Pharmaceuticals. [Registered Activity]

 

 

Products/ Services :

ITC Code No.

 

Product Descriptions

98041000

Drugs and Medicine

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

 

Products :

Not Available

Countries :

Not Available

 

 

Imports :

 

Products :

Raw Materials

Countries :

China

 

 

Terms :

 

Selling :

L/C, Cheque and Credit [60,90 Days]

 

 

Purchasing :

L/C, Cheque and Credit [60,90 Days]

 

PRODUCTION STATUS: (NOT AVAILABLE)

 

 

GENERAL INFORMATION

 

Suppliers :

Reference:

Not Divulged

Name of the Person (Designation):

--

Contact Number:

--

Since how long known:

--

Maximum limit dealt:

--

Experience:

--

Remark

--

 

 

Customers :

Retailers and Manufacturers 

 

Reference:

Not Divulged

Name of the Person (Designation):

--

Contact Number:

--

Since how long known:

--

Maximum limit dealt:

--

Experience:

--

Remark

--

 

 

No. of Employees :

150 (Approximately)

 

 

Bankers :

 

Bank Name:

HDFC Bank Limited

Branch:

W 6, Main Gurudwara Road, Poonta Sahib, Siramaur, Paonta Sahib, Sirmour, Himachal Pradesh, India

Person Name (with Designation):

--

Contact Number:

1800-425-4332

Name of Account Holder:

COPMED PHARMACEUTICALS PRIVATE LIMITED

Account Number:

14388640000053

IFSC Code: HDFC0001438

Account Since (Date/ Year of A/c Opening):

--

Average Balance Maintained (Optional):

--

Credit Facilities Enjoyed (CC/OD/Term Loan):

--

Account Operation:

--

Remarks:

Number is continuously ringing

 

·         State Bank of India

Branch Taruwala, Distt. Sirmour, Paonta Sahib – 173025, Himachal Pradesh, India

 

 

Facilities :

---

 

 

 

Auditors :

 

Name :

Gupta Shiv and Company

Chartered Accountants

Address :

Ca House, Ist Floor, Opposite Sharma Smarak, Behind Mool Chand Hospital, Baccha Park, Meerut, Uttar Pradesh, India

PAN No.:

AARPG1108N

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Enterprises which are owned, or have significant influence of or are partners

with Key management personnel and their relatives :

·         Alpha Polyplast

·         Ambala Packaging Industry

·         A.S. Packers

·         A to Z Packers

·         EMM Bee Healthcare

·         Freinds Engineering Works

·         J K Printpack

·         Life Star Pharma Private Limited

·         Mankind Pharma Limited

·         Medipack Innovations Private Limited

·         N. S. Industries

·         Pharma Force Lab

·         Pharma Pet Industries

·         Printman

·         Relax Pharmaceuticals Private Limited

·         Sirmour Pet Industries

·         Standard Manufacturing Corporation

·         Vetbesta Labs

 


 

CAPITAL STRUCTURE

 

AS ON: 31.03.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

200000

Equity Shares

INR 100/- each

INR 20.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

96000

Equity Shares

INR 100/- each

INR 9.600 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in INR Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

31.03.2015

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

9.600

9.600

9.600

(b) Reserves and Surplus

769.821

587.752

606.562

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

779.421

597.352

616.162

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

1.019

1.019

1.019

(b) Deferred tax liabilities (Net)

0.000

0.033

2.304

(c) Other long-term liabilities

0.000

0.000

0.000

(d) long-term provisions

3.401

2.444

4.556

Total Non-current Liabilities (3)

4.420

3.496

7.879

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

0.000

0.000

0.000

(b) Trade payables

360.961

281.627

278.566

(c) Other current liabilities

44.416

5.453

23.444

(d) Short-term provisions

7.034

6.923

68.489

Total Current Liabilities (4)

412.411

294.003

370.499

 

 

 

 

TOTAL

1196.252

894.851

994.540

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

295.453

256.019

290.538

(ii) Intangible Assets

1.907

1.410

0.332

(iii) Tangible assets capital work-in-progress

0.839

0.733

2.900

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

77.595

72.920

56.416

(c) Deferred tax assets (net)

2.702

0.000

0.000

(d) Long-term loans and advances

58.127

75.326

78.845

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

436.623

406.408

429.031

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

294.845

220.907

284.435

(c) Trade receivables

271.687

179.478

210.491

(d) Cash and bank balances

186.820

35.347

39.357

(e) Short-term loans and advances

6.277

52.711

31.226

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

759.629

488.443

565.509

 

 

 

 

TOTAL

1196.252

894.851

994.540

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

Total Revenue from operations

2474.475

1835.640

1854.373

 

Other Income

26.925

5.044

2.113

 

TOTAL

2501.400

1840.684

1856.486

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

2137.997

1489.789

1474.536

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(71.523)

26.954

37.387

 

Employee benefit expense

60.514

52.599

46.523

 

CSR expenditure

3.000

6.000

0.000

 

Other expenses

81.657

72.113

64.215

 

TOTAL

2211.645

1647.455

1622.661

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

289.755

193.229

233.825

 

 

 

 

 

Less

FINANCIAL EXPENSES

0.009

0.002

0.011

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

289.746

193.227

233.814

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

45.828

54.195

61.661

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

243.918

139.032

172.153

 

 

 

 

 

Less

TAX

61.848

37.484

36.200

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

182.070

101.548

135.953

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Materials

704.898

408.669

403.912

 

TOTAL IMPORTS

704.898

408.669

403.912

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

1896.56

1057.78

1416.17

 

 

PARTICULARS

 

 

 

31.03.2018

Sales Turnover (Approximately)

 

 

2000.000

 

 

 

[Due to GST and less sales]

 

Expected Sales (2018-2019): INR 2700.000 Million [Due to Business Growth]

 

The above information has been parted by Mr. Rajeev Gupta [Accounts Manager]

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

NA

NA

NA

 

 

 

 

Net cash flows from (used in) operations

262.142

258.751

180.815

 

 

 

 

Net cash flows from (used in) operating activities

197.559

218.995

122.627

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

40.08

35.69

41.43

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

9.11

10.23

8.81

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

61.62

69.00

68.95

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

0.98

0.87

0.82

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.97

0.75

0.80

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.35

0.33

0.37

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.00

0.00

0.00

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

0.53

0.49

0.60

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.38

0.43

0.48

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

32195.00

96614.50

21256.82

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Net Profit Margin

((PAT / Sales) * 100)

%

7.36

5.53

7.33

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

15.22

11.35

13.67

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

23.36

17.00

22.06

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

1.84

1.66

1.53

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

1.13

0.91

0.76

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.65

0.67

0.62

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

0.11

0.11

0.11

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

1.84

1.66

1.53

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Share Capital

9.600

9.600

9.600

Reserves & Surplus

606.562

587.752

769.821

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

616.162

597.352

779.421

 

 

 

 

Long-term borrowings

1.019

1.018

1.019

Short term borrowings

0.000

0.000

0.000

Total borrowings

1.019

1.018

1.019

Debt/Equity ratio

0.002

0.002

0.001

 

 


 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

1854.373

1835.640

2474.475

 

 

(1.010)

34.802

 

 


 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

1854.373

1835.640

2474.475

Profit/ (Loss)

135.953

101.548

182.070

 

7.33 %

5.53 %

7.36 %

 

 

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report

(Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

Yes

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

Yes

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last four years

Yes

27

Reasons for variation <> 20%

Yes

28

Estimation for coming financial year

Yes

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

 

 

INDEX OF CHARGES

 

SNO

SRN

CHARGE ID

CHARGE HOLDER NAME

DATE OF CREATION

DATE OF MODIFICATION

DATE OF SATISFACTION

AMOUNT

ADDRESS

1

B56078306

10248381

HDFC BANK LIMITED

30/09/2010

30/07/2012

-

200000000.0

HDFC BANK HOUSESENAPATI BAPAT MARGLOWER PAREL WMUMBAIMH400013IN

2

G15842388

10248378

HDFC BANK LIMITED

30/09/2010

22/08/2016

-

287500000.0

HDFC BANK HOUSESENAPATI BAPAT MARGLOWER PAREL WMUMBAIMH400013IN

3

A69767085

10175884

Member Secretary

05/09/2009

-

-

3000000.0

Single Window Clearance AgencyPaonta SahibSirmourHP173025IN

4

A95613402

80005470

STATE BANK OF INDIA

27/09/2005

09/01/2010

31/08/2010

50000000.0

BRANCH TARUWALADISTT. SIRMOURPAONTA SAHIBHP173025IN

 

 

 

 

UNSECURED LOANS

 

PARTICULARS

31.03.2017

(INR In Million)

31.03.2016

(INR In Million)

LONG-TERM BORROWINGS

 

 

Loans and advances from others

1.019

1.019

 

 

 

Total

 

1.019

 

1.019

 

 

 

NATURE OF BUSINESS

 

The Company's main line of business is Manufacturing Drugs and Pharmaceuticals. There was no change in the nature of the business of the Company during the financial year ended on 31st March, 2017.


FIXED ASSETS:

 

Tangible Assets

 

·         Land

·         Buildings

·         Plant and Equipment

·         Furniture and Fixtures

·         Vehicles

·         Office Equipment

·         Computer Equipments

 

 

 

 

 

 

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 68.21

UK Pound

1

INR 91.43

Euro

1

INR 80.24

 

 

INFORMATION DETAILS

 

Information Gathered by :

RUB

 

 

Analysis Done by :

NIY

 

 

Report Prepared by :

IND

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.